Justice Dept.: OptumRx Agrees to Pay $20M to Resolve Allegations That It Filled Certain Opioid Prescriptions in Violation of the Controlled Substances Act
June 28, 2024
June 28, 2024
WASHINGTON, June 28 -- The U.S. Department of Justice issued the following news release:
OptumRx Inc., a prescription drug benefit provider, has agreed to pay $20 million to resolve allegations that it improperly filled certain opioid prescriptions in violation of the Controlled Substances Act.
The settlement resolves an investigation initiated by the Drug Enforcement Administration (DEA) into whether, between April 2013 and April 2015, OptumRx improperly filled certain . . .
OptumRx Inc., a prescription drug benefit provider, has agreed to pay $20 million to resolve allegations that it improperly filled certain opioid prescriptions in violation of the Controlled Substances Act.
The settlement resolves an investigation initiated by the Drug Enforcement Administration (DEA) into whether, between April 2013 and April 2015, OptumRx improperly filled certain . . .